about
Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.Antimicrobial therapy in neonatal intensive care unitStrategies for the prevention of hospital-acquired infections in the neonatal intensive care unit.Stem cell therapy for neonatal diseases associated with preterm birth.Prevention of early onset group B streptococcal disease: controversial issues.Inherited human IRAK-1 deficiency selectively impairs TLR signaling in fibroblastsDrug transporters and renal drug disposition in the newborn.Neonatal Group B Streptococcal Disease in Otherwise Healthy Infants: Failure of Specific Neonatal Immune ResponsesFrom the lab to the bedside: the present of research, i.e. the future of neonatology.New possibilities of prevention of infection in the newborn.Emerging viral infections in neonatal intensive care unit.Use and misuse of antibiotics in the neonatal intensive care unit.Which is the optimal algorithm for the prevention of neonatal early-onset group B streptococcus sepsis?IUGR and infections.Neonatal infections due to multi-resistant strains: Epidemiology, current treatment, emerging therapeutic approaches and prevention.Expression and function of toll-like receptors in human circulating endothelial colony forming cells.Familial segregation of group B streptococcal infection in a consanguineous kindred.Genomic alterations in human umbilical cord-derived mesenchymal stromal cells call for stringent quality control before any possible therapeutic approach.Selecting girls with precocious puberty for brain imaging: validation of European evidence-based diagnosis rule.Human herpesvirus-6 associated neonatal urticaria multiforme.The red cell distribution width (RDW): value and role in preterm, IUGR (intrauterine growth restricted), full-term infants.Neonatal antibiotic prophylaxis for the prevention of early- and late-onset Group B streptococcal sepsis.Diagnostic performance of triggering receptor expressed on myeloid cells-1 and CD64 index as markers of sepsis in preterm newborns.Intersociety policy statement on the use of whole-exome sequencing in the critically ill newborn infant.Italia-Netherland PhD Program: the I.O. PhD Research Program.Human milk feeding prevents retinopathy of prematurity (ROP) in preterm VLBW neonates.Canonical transient receptor potential 3 channel triggers vascular endothelial growth factor-induced intracellular Ca2+ oscillations in endothelial progenitor cells isolated from umbilical cord blood.Circulating endothelial progenitor cells in preterm infants with bronchopulmonary dysplasia.A novel LAMA3 mutation in a newborn with junctional epidermolysis bullosa herlitz type.Neonatal Bacterial and Fungal InfectionsStem cells for bronchopulmonary dysplasia and intraventricular haemorrhage repair in preterm infantsStrategies for the prevention of hospital-acquired infections in the neonatal intensive care unitDeterminants of HIV-1 reservoir size and long-term dynamics during suppressive ARTSusceptibility to infection in early life: a growing role for human genetics
P50
Q35144610-49CE4592-8705-4DF5-8E86-1C08E01AE494Q35540654-BB657788-8FE1-451D-A154-48BB438DFCDFQ37105475-89FC3E0B-B5AC-4A4E-B69D-FD0F8589B7DFQ37144573-49E57014-2797-4401-AE17-D90587C7E877Q37589515-FB39C8DD-BB01-4D64-9915-C8B48E2BF0B9Q37612571-3E147AED-F0E9-455A-BCE6-72527A762353Q37635181-F1620744-C311-4618-96DC-0F7354F49BF2Q37683149-118A780F-2589-432E-8C43-69A9A6D271EBQ37833209-4AB2B625-8570-400E-97B3-29E9FCDD43BCQ37900319-D39C2431-356B-472B-981B-D8BAA739C28CQ37923959-4FF6AAE6-7FB1-4CA7-8AA1-23ED77265C89Q38041592-148A7F45-3132-462C-9A04-F9284BC79D00Q38202774-BF8E813F-9F9E-4E6A-82FE-73ABA659D967Q38202777-5196A01C-88C6-4495-B1F2-55C3E51CFF4FQ38370021-CC519537-6255-4F1F-9CDF-18BF99DCFA98Q40471374-5E06B0CA-43BF-4719-B103-2B592D196174Q40488373-176E8C3B-06FA-478A-BA31-F583648075B4Q43600880-C34598B2-5CB9-4D49-ADB9-354A17951D9DQ44626960-4241F1FB-AAE7-434B-B5DC-077685E81D02Q44879607-87B2EE20-50D9-4169-A4C8-013B2CCCC839Q44944864-AA4EE60A-B9EB-4FCA-9327-821CD5DEBB02Q44994516-9651D4C5-A5CE-407E-A6E8-F05F1D02D9F7Q46185953-0BCDEB77-E8D1-43CD-9903-D017BBC64C66Q47114779-D0BA294E-5054-4599-9083-805ACF20CCDAQ48925882-1028CEE9-FB3A-4AD9-82CB-3CD7C172F56BQ50798321-B586B25B-D343-46AC-908A-E90D1E9B881DQ50986422-09A1D254-78B4-49DA-9E9D-F9F7EF00B601Q52594464-D5C8D92A-9B0F-4B51-987F-0108643629B4Q53298205-4C5448CA-4CB4-4E3F-8D29-E9870F7FD60AQ62659063-652425C1-FF14-492F-B8BE-49F4C6A7DA9AQ62659065-16070F24-5DFD-42A8-8252-1130C3DA0ACFQ62659068-289278EF-27D5-4713-A968-8506E94206E3Q92034495-B4A7563E-CB78-4FDE-8F4B-2136D15A8647Q92611846-27428418-7E68-47D5-BB1B-D0AFAA434985
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alessandro Borghesi
@ast
Alessandro Borghesi
@en
Alessandro Borghesi
@es
Alessandro Borghesi
@nl
Alessandro Borghesi
@sl
type
label
Alessandro Borghesi
@ast
Alessandro Borghesi
@en
Alessandro Borghesi
@es
Alessandro Borghesi
@nl
Alessandro Borghesi
@sl
prefLabel
Alessandro Borghesi
@ast
Alessandro Borghesi
@en
Alessandro Borghesi
@es
Alessandro Borghesi
@nl
Alessandro Borghesi
@sl
P1053
K-8157-2016
P106
P1153
16300715700
P21
P2798
P31
P3829
P496
0000-0002-8773-9144